Guillain-Barré Syndrome in a 28-Year-Old Female with Antecedent COVID 19 Infection: A Case Report
Main Article Content
Abstract
Various neurological manifestations have been observed throughout the SARS-CoV-2 disease (COVID-19) pandemic. However, few cases of Guillain-Barré syndrome (GBS) in association with COVID-19 have been described. We submit a unique case of a previously healthy 28-year-old woman who presented with ascending weakness including facial diplegia, areflexia and respiratory compromise consistent with GBS Miller Fisher variant in the setting of recent COVID-19 infection one month prior to symptom onset.
Article Details
How to Cite
HIRST, Priscilla; FEDELES, Benjamin Tate; SCHLESINGER, Joseph J..
Guillain-Barré Syndrome in a 28-Year-Old Female with Antecedent COVID 19 Infection: A Case Report.
Medical Research Archives, [S.l.], v. 9, n. 9, sep. 2021.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/2546>. Date accessed: 23 nov. 2024.
doi: https://doi.org/10.18103/mra.v9i9.2546.
Section
Case Reports
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. doi:10.1001/jamaneurol.2020.1127
2. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-2184. doi:10.1007/s00415-020-09929-7
3. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653-1666. doi:10.1016/S0140-6736(05)67665-9
4. Piccione EA, Salame K, Katirji B (2014) Guillain-Barré syndrome and related disorders. In: Katirji B, Kaminski HJ, Ruff RL (eds) Neuromuscular disorders in clinical practice. Springer New York, New York, NY, pp 573–603
5. Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports [published correction appears in Neurol Sci. 2020 Sep 23;:]. Neurol Sci. 2020;41(11):3149-3156. doi:10.1007/s10072-020-04693-y
6. Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020;382(23):2268-2270. doi:10.1056/NEJMc2008597
7. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-58. doi:10.1016/j.ijid.2020.03.062
8. Gupta A, Paliwal VK, Garg RK. Is COVID-19-related Guillain-Barré syndrome different?. Brain Behav Immun. 2020;87:177-178. doi:10.1016/j.bbi.2020.05.051
9. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255(2):57-65. doi:10.1056/NEJM195607122550201
10. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993;56(2):204-206. doi:10.1136/jnnp.56.2.204
11. Yuki N, Hartung HP. Guillain-Barré syndrome [published correction appears in N Engl J Med. 2012 Oct 25;367(17):1673]. N Engl J Med. 2012;366(24):2294-2304. doi:10.1056/NEJMra1114525
12. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020;19(5):383-384. doi:10.1016/S1474-4422(20)30109-5
13. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-e605. doi:10.1212/WNL.0000000000009619
14. Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;95(5):221-223. doi:10.1212/WNL.0000000000009700
15. Kamel WA. et al. Guillain-Barré syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature. Dubai Med J. 2021;4:107-111.
16. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi:10.1016/j.jcv.2020.104362
2. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-2184. doi:10.1007/s00415-020-09929-7
3. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653-1666. doi:10.1016/S0140-6736(05)67665-9
4. Piccione EA, Salame K, Katirji B (2014) Guillain-Barré syndrome and related disorders. In: Katirji B, Kaminski HJ, Ruff RL (eds) Neuromuscular disorders in clinical practice. Springer New York, New York, NY, pp 573–603
5. Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports [published correction appears in Neurol Sci. 2020 Sep 23;:]. Neurol Sci. 2020;41(11):3149-3156. doi:10.1007/s10072-020-04693-y
6. Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020;382(23):2268-2270. doi:10.1056/NEJMc2008597
7. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-58. doi:10.1016/j.ijid.2020.03.062
8. Gupta A, Paliwal VK, Garg RK. Is COVID-19-related Guillain-Barré syndrome different?. Brain Behav Immun. 2020;87:177-178. doi:10.1016/j.bbi.2020.05.051
9. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255(2):57-65. doi:10.1056/NEJM195607122550201
10. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993;56(2):204-206. doi:10.1136/jnnp.56.2.204
11. Yuki N, Hartung HP. Guillain-Barré syndrome [published correction appears in N Engl J Med. 2012 Oct 25;367(17):1673]. N Engl J Med. 2012;366(24):2294-2304. doi:10.1056/NEJMra1114525
12. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020;19(5):383-384. doi:10.1016/S1474-4422(20)30109-5
13. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-e605. doi:10.1212/WNL.0000000000009619
14. Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;95(5):221-223. doi:10.1212/WNL.0000000000009700
15. Kamel WA. et al. Guillain-Barré syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature. Dubai Med J. 2021;4:107-111.
16. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi:10.1016/j.jcv.2020.104362